• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

5.870 +0.060 (+1.03%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cytek Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
May 16, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Why Shares of Cytek Biosciences Dropped This Week ↗
May 12, 2023
Cytek grew revenue and losses in the first quarter. 
Via The Motley Fool
News headline image
Where Cytek Biosciences Stands With Analysts ↗
May 10, 2023
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
May 10, 2023
 
Via Benzinga
News headline image
Recap: Cytek Biosciences Q1 Earnings ↗
May 09, 2023
 
Via Benzinga
News headline image
Cytek Biosciences Acquires Flow Cytometry & Imaging Business From DiaSorin ↗
February 14, 2023
 
Via Benzinga
Cytek Biosciences Earnings Perspective: Return On Capital Employed ↗
December 15, 2022
 
Via Benzinga
News headline image
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
May 10, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
Via Benzinga
News headline image
Cytek Biosciences Reports First Quarter 2023 Financial Results
May 09, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
April 26, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 105% to $0.1730 after the company issued a letter to shareholders. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
April 26, 2023
 
Via Benzinga
News headline image
Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023
April 20, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Introduces New 20-Color AML Panel
March 07, 2023
Optimized for Cytek Cell Analysis Systems; Single-Tube Panel Accelerates Acute Myeloid Leukemia Research and MRD Detection 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
March 03, 2023
 
Via Benzinga
News headline image
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
February 28, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
February 14, 2023
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users. 
Via Benzinga
News headline image
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
February 13, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
February 07, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
February 07, 2023
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Participate in Upcoming Investor Conferences
February 06, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Oak Street Health, PriceSmart And Some Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗
January 10, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More ↗
December 15, 2022
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
November 21, 2022
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Introduces Cytek Cloud
November 15, 2022
New Digital Ecosystem Supports Full Spectrum Flow Cytometry Research – from Panel Design to Data Acquisition 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Reports Third Quarter 2022 Financial Results
November 09, 2022
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Earnings Outlook For Cytek Biosciences ↗
November 08, 2022
Cytek Biosciences (NASDAQ:CTKB) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Cytek... 
Via Benzinga
News headline image
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
October 26, 2022
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference
October 26, 2022
From Cytek Biosciences, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap